BioCentury
ARTICLE | Company News

Horizon Discovery, Abcam deal

October 12, 2015 7:00 AM UTC

Horizon granted Abcam exclusive rights to more than 1,800 diploid and haploid cell line models developed using Horizon’s X-MAN technology, which Abcam will use to validate the function of its antibodies. Horizon will also develop additional haploid cell lines to validate new antibodies from Abcam. ...